2,386
Views
22
CrossRef citations to date
0
Altmetric
Research Article

Glucosinolates profile, volatile constituents, antimicrobial, and cytotoxic activities of Lobularia libyca

, , &
Pages 3257-3263 | Received 29 Sep 2015, Accepted 04 Aug 2016, Published online: 06 Sep 2016

Figures & data

Figure 1. The general structure of glucosinolates and their enzymatic degradation products (adapted from Rask et al. Citation2000).

Figure 1. The general structure of glucosinolates and their enzymatic degradation products (adapted from Rask et al. Citation2000).

Table 1. GC-MS analysis of GLS hydrolysis products of L. libyca.

Table 2. GC-MS analysis of miscellaneous volatile compounds of L. libyca seeds.

Table 3. LC-MS analysis of intact glucosinolates of L. libyca seeds.

Table 4. Antimicrobial activities of L. libyca seed hydrolysate.

Table 5. MIC values of L. libyca seed hydrolysate and standards against S. aureus, P. aeruginosa and C. albicans.

Figure 2. Cytotoxic activity of L. libyca seeds' hydrolysate. N = 3 ± S. D.

Figure 2. Cytotoxic activity of L. libyca seeds' hydrolysate. N = 3 ± S. D.

Table 6. IC50 of seed hydrolysate and doxorubicin against tested cell lines.

Figure 3. Glucosinolates identified in L. libyca plant.

Figure 3. Glucosinolates identified in L. libyca plant.
Supplemental material

Al-Gendy_et_al__Supplementary_Materials.docx

Download MS Word (561.5 KB)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.